Dr. Daniel Aaron Pollyea MD
Hematologist-Oncologist | Hematology & Oncology
875 Blake Wilbur Drive Stanford CA, 94305About
Dr. Daniel Pollyea is a hematologist oncologist practicing in Aurora, CO. Dr. Pollyea specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
- Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.
- Omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia.
- Expert insights into the contemporary management of older adults with acute myeloid leukemia.
- Aldehyde dehydrogenases in acute myeloid leukemia.
- The effects of alcohol and aldehyde dehydrogenases on disorders of hematopoiesis.
- Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations.
- Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics.
- Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series.
- SomVarIUS: somatic variant identification from unpaired tissue samples.
- Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.
- Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
- Isocitrate dehydrogenase mutations in myeloid malignancies.
- ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia.
- Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells.
Clinical Trials
- Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
- TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea
- Hu5F9-G4 Monotherapy or Hu5F9-G4 in Combination With Azacitidine in Patients With Hematological Malignancies
- Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML
- PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant
Dr. Daniel Aaron Pollyea MD's Practice location
Dr. Daniel Aaron Pollyea MD's reviews
Write ReviewPatient Experience with Dr. Pollyea
Recommended Articles
- Survey Shows Lack of Blood Cancer Knowledge Among Americans
If anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...
- 'Robocop' Stem Cells Developed to Fight Cancer
Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...
- Is Lymphoma-related PTSD Possible?
PTSD is something that one may not think of right away when thinking of chronic or life-threatening illnesses, but it should not be overlooked. Post-traumatic stress disorder, or PTSD, can affect all aspects of a person’s life and requires treatment by a specialist.The Diagnostic and Statistical...
- Breaking News on the Treatment of Follicular Lymphoma
Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
- Living with Lymphoma Day by Day
A majority of individuals diagnosed with lymphoma find that they have to make a great deal of adjustments to their lives. There are several physical, emotional, social, and everyday obstacles from diagnosis to remission.Living with lymphoma can be different for every individual, which is why it is...
- How to Show Social Support for Lymphoma
A cancer diagnosis can shake an individual’s world, and not just the physical aspects of their world, but all corners of it. Although cancer attacks the body, it necessarily also affects a person’s mental and emotional state, and it can have an impact on other people close to the affected...
Nearby Providers
- Dr. Joseph Andrew Mollick M.D.875 Blake Wilbur Drive, Mc5820 Stanford CA 94305
- Dr. Saul Rosenberg M.D.269 Campus Dr Stanford CA 94305
- Dr. Alexander Dimitrios Colevas MD875 Blake Wilbur Drive Stanford CA 94305
- Dr. Wen-kai Weng M.D., PH.D.300 Pasteur Dr Stanford CA 94305
- Dr. James M. Ford MD300 Pasteur Dr Stanford CA 94305
- Dr. Bruno Carneiro de Medeiros MD269 Campus Dr Stanford CA 94305